Herbert Loong: Welcoming Boehringer Ingelheim’s Clinical Operations Managment Team for a brief visit at our CUHK Medicine Department of Clinical Oncology

Herbert Loong shared a post on LinkedIn:

“Had the pleasure of welcoming Boehringer Ingelheim’s Clinical Operations Managment Team, China, for a brief visit at our Chinese University of Hong Kong (CUHK) Medicine Department of Clinical Oncology. We are happy to be able to collaborate on multiple clinical trials opportunities in lung cancer and sarcomas, and look forward to further enhance this continual partnership.”

Source: Herbert Loong/LinkedIn

Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.

Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.